{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:04:27Z","timestamp":1790355867463,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T00:00:00Z","timestamp":1281484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s11940-010-0091-8","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T10:02:55Z","timestamp":1281434575000},"page":"529-538","source":"Crossref","is-referenced-by-count":46,"title":["Pharmacologic Treatment of Behavioral Symptoms Associated With Autism and Other Pervasive Developmental Disorders"],"prefix":"10.1007","volume":"12","author":[{"given":"Logan K.","family":"Wink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,11]]},"reference":[{"key":"91_CR1","first-page":"217","volume":"2","author":"L Kanner","year":"1943","unstructured":"Kanner L: Autistic disturbances of affective contact. J Nerv Child 1943, 2:217\u2013250.","journal-title":"J Nerv Child"},{"key":"91_CR2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4th. Washington DC: American Psychiatric Press; 1994.","edition":"4"},{"issue":"1","key":"91_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1352\/2009.114:23-41","volume":"114","author":"P Howlin","year":"2009","unstructured":"Howlin P, Magiati I, Charman T: Systematic review of early intensive behavioral interventions for children with autism. Am J Intellect Dev Disabil 2009, 114(1):23\u201341.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"11","key":"91_CR4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","volume":"62","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2005","unstructured":"Research Units on Pediatric Psychopharmacology Autism Network: Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 2005, 62(11):1266\u20131274.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"91_CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/cap.2006.16.589","volume":"16","author":"L Scahill","year":"2006","unstructured":"Scahill L, Aman MG, McDougle CJ, et al.: A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol 2006, 16(5):589\u2013598.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"91_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DBP.0b013e3181739b9d","volume":"29","author":"BL Handen","year":"2008","unstructured":"Handen BL, Sahl R, Hardan AY: Guanfacine in children with autism and\/or intellectual disabilities. J Dev Behav Pediatr 2008, 29(4):303\u2013308.","journal-title":"J Dev Behav Pediatr"},{"key":"91_CR7","unstructured":"Physicians Desk Reference online. Available at http:\/\/www.pdr.net\/home\/pdrHome.aspx . Accessed May 2010."},{"issue":"10","key":"91_CR8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/01.chi.0000231976.28719.2a","volume":"45","author":"LE Arnold","year":"2006","unstructured":"Arnold LE, Aman MG, Cook AM, et al.: Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 2006, 45(10):1196\u20131205.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"91_CR9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/cap.2006.16.599","volume":"16","author":"DJ Posey","year":"2006","unstructured":"Posey DJ, Wiegand RE, Wilkerson J, et al.: Open-label atomoxetine for attention-deficit\/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol 2006, 16(5):599\u2013610.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"91_CR10","volume-title":"Essential Pharmacology The Prescriber\u2019s Guide. Revised and Updated Edition","author":"SM Stahl","year":"2006","unstructured":"Stahl SM: Essential Pharmacology The Prescriber\u2019s Guide. Revised and Updated Edition. New York: Cambridge University Press; 2006."},{"issue":"11","key":"91_CR11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.1996.01830110037005","volume":"53","author":"CJ McDougle","year":"1996","unstructured":"McDougle CJ, Naylor ST, Cohen DJ, et al.: A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996, 53(11):1001\u20131008.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"91_CR12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.npp.1300627","volume":"30","author":"E Hollander","year":"2005","unstructured":"Hollander E, Phillips A, Chaplin W, et al.: A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 2005, 30(3):582\u2013589.","journal-title":"Neuropsychopharmacology"},{"key":"91_CR13","unstructured":"Autism Speaks Announces Results Reported for the Study of Fluoxetine in Autism (SOFIA), First Industry-Sponsored Trial for the Autism Clinical Trials Network (ACTN) 2009. New York, NY: Autism Speaks; February 18, 2009. Available at http:\/\/www.autismspeaks.org\/press\/as_announces_sofia_results.php . Accessed May 2010."},{"issue":"6","key":"91_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","volume":"66","author":"BH King","year":"2009","unstructured":"King BH, Hollander E, Sikich L, et al.: Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 2009, 66(6):583\u2013590.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"91_CR15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2002","unstructured":"Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002, 347(5):314\u2013321.","journal-title":"N Engl J Med"},{"issue":"11","key":"91_CR16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","volume":"48","author":"RN Marcus","year":"2009","unstructured":"Marcus RN, Owen R, Kamen L, et al.: A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009, 48(11):1110\u20131119.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"91_CR17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L, Marcus RN, et al.: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009, 124(6):1533\u20131540.","journal-title":"Pediatrics"},{"issue":"7","key":"91_CR18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","volume":"162","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2005","unstructured":"Research Units on Pediatric Psychopharmacology Autism Network: Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6\u00a0months. Am J Psychiatry 2005, 162(7):1361\u20131369.","journal-title":"Am J Psychiatry"},{"key":"91_CR19","first-page":"CD006569","volume":"4","author":"K Komossa","year":"2009","unstructured":"Komossa K, Rummel-Kluge C, Schmid F, et al.: Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2009, 4:CD006569.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"91_CR20","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1176\/appi.ajp.161.11.2115","volume":"161","author":"DJ Posey","year":"2004","unstructured":"Posey DJ, Kem DL, Swiezy NB, et al.: A pilot study of D-cycloserine in subjects with autistic disorder. Am J Psychiatry 2004, 161(11):2115\u20132117.","journal-title":"Am J Psychiatry"},{"key":"91_CR21","unstructured":"Posey DJ, Stigler KA, Erickson CA, et al.: A double-blind placebo-controlled study of D-cycloserine in children with autistic disorder [abstract P3.53:83]. Presented at the 55th Annual Meeting of the American Academy of Child and Adolescent Psychiatry Scientific Proceedings, Chicago, IL; October 29\u2013November 1, 2008."},{"issue":"1","key":"91_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-006-0518-9","volume":"191","author":"CA Erickson","year":"2007","unstructured":"Erickson CA, Posey DJ, Stigler KA, et al.: A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) 2007, 191(1):141\u2013147.","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"91_CR23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","volume":"22","author":"MG Chez","year":"2007","unstructured":"Chez MG, Burton Q, Dowling T, et al.: Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 2007, 22(5):574\u2013579.","journal-title":"J Child Neurol"},{"issue":"1","key":"91_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10673220903523615","volume":"18","author":"K Macdonald","year":"2010","unstructured":"Macdonald K, Macdonald TM: The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry 2010, 18(1):1\u201321.","journal-title":"Harv Rev Psychiatry"},{"issue":"4","key":"91_CR25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","volume":"61","author":"E Hollander","year":"2007","unstructured":"Hollander E, Bartz J, Chaplin W, et al.: Oxytocin increases retention of social cognition in autism. Biol Psychiatry 2007, 61(4):498\u2013503.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"91_CR26","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0910249107","volume":"107","author":"E Andari","year":"2010","unstructured":"Andari E, Duhamel JR, Zalla T, et al.: Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 2010, 107(9):4389\u20134394.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-010-0091-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0091-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:56Z","timestamp":1559437016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-010-0091-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["91"],"URL":"https:\/\/doi.org\/10.1007\/s11940-010-0091-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,11]]}}}